Table 2.
Age at start of experiment | Age at end of experiment | Treatment | Wound | N | %IdU-LRCs | %CldU or EdU positive cells | % Double-labelled cells | % of IdU-LRCs active |
---|---|---|---|---|---|---|---|---|
8 week | 23 week | CldU at 0–24 h post-wounding | No | 6 | 23. 35 ± 0.84 | 20.39 ± 1.16 | 1.01 ± 0.31 | 4.5 ± 1.4 |
8 week | 23 week | CldU at 0–24 h post-wounding | Yes | 6 | 18.02 ± 4.33 | 16.91 ± 1.86 | 5.12 ± 1.41 | 32.8 ± 10.0 |
37 week | 52 week | CldU at 0–24 h post-wounding | No | 4 | 22.06 ± 2.43 | 17.95 ± 3.16 | 2.51 ± 1.06 | 15.9 ± 6.9 |
37 week | 52 week | CldU at 0–24 h post-wounding | Yes | 4 | 25.01 ± 4.32 | 12.73 ± 0.58 | 3.53 ± 1.48 | 12.2 ± 5.6 |
8 week | 23 week | EdU at 24–48 h post-wounding | No | 12 | 8.79 ± 1.37 | 20.05 ± 2.03 | 3.41 ± 0.75 | 46.0 ± 9.44 |
8 week | 23 week | EdU at 24–48 h post-wounding | Yes | 12 | 11.39 ± 2.37 | 32.71 ± 1.92 | 10.82 ± 2.37 | 86.5 ± 8.16 |